The Board of Directors of the Company is very pleased to announce Arjan’s promotion to CEO of MLSS and appointment as CEO of the Company. The Board of Directors of MLSS believes it is well deserved as Arjan has been instrumental in implementing successful sales and marketing activities as well as accelerating the commercialization of CompuFlo® and CathCheck™. Arjan’s strong leadership will be invaluable as MLSS and the Company work towards their joint goal of establishing the technology as standard of care in epidural procedures during labor and delivery, around the world.
The Board of Directors would like to express its sincere gratitude to Leonard Osser for his significant contributions and outstanding leadership he provided to the Company over the years. Mr. Osser has executed on a focused vision of advancing and delivering MLSS’s computerized drug delivery instruments to market and we look forward to continuing to benefit from his thoughtful counsel to the Company. MLSS has been preparing this transition for some time and looks forward to Arjan’s participation in his new role as CEO as the Company prepares for the next phase of our growth.
Information concerning Mr. Haverhals is attached to this report.
Legal basis: Section 3.1 point 7) of the Exhibit 3 to the Alternative Trading System Rules "Current and Periodical Information in the Alternative Trading System on the NewConnect Market".
| Załączniki |
| 20210514_192255_0000133455_0000129626.pdf |
Źródło:Komunikaty spółek (EBI)
